Literature DB >> 8924742

Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in south-western Germany.

F F Wagner1, D Kasulke, M Kerowgan, W A Flegel.   

Abstract

BACKGROUND: Current estimates of blood group frequencies in Germany were often derived from studies involving less than 12,000 individuals. The frequency of the D category VI was unknown.
METHODS: ABO. Kell, and Rhesus blood group data of more than 600,000 donors were reviewed. Allele frequencies were derived by the maximum-likelihood method. The frequency of D category VI was determined in more than 70,000 Rhesus typings.
RESULTS: ABO allele frequencies were: O: 0.640, A: 0.279. B: 0.081. Rhesus haplotype frequencies were: cde: 0.394, CDe: 0.431, cDE: 0.136, cDe: 0.021, and Cde: 0.011. D category VI represented 7%, of all weak D (formerly D(u)). The 95% confidence interval for the D category VI frequency was 1:3,600-1:11,200. Kell allele frequencies were: K: 0.040, and k: 0.960, 95% confidence intervals for rare phenotypes were: Oh: 1:88,000-1:1,760,000, p: 1:200,000-1:5,200,000. Rh(null): 1:180,000-1:10,300,000, and D-deletion: 1: 180,000-0.
CONCLUSIONS: We presented refined estimates of ABO, Rhesus D and Kell blood group frequencies and established reliable frequency estimates for Rhesus haplotype and some rare blood groups. The prevalence of D category VI was about 0.02%, which necessitates specific detection for Rh-D-negative transfusion therapy. A protocol is presented for Rh D typing in transfusion recipients. which obviates the need for an antiglobulin test.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8924742     DOI: 10.1159/000223144

Source DB:  PubMed          Journal:  Infusionsther Transfusionsmed        ISSN: 1019-8466


  29 in total

Review 1.  Molecular genetics and clinical applications for RH.

Authors:  Willy A Flegel
Journal:  Transfus Apher Sci       Date:  2011-01-28       Impact factor: 1.764

2.  The genetics of the Rhesus blood group system.

Authors:  Willy A Flegel
Journal:  Blood Transfus       Date:  2007-04       Impact factor: 3.443

3.  Rh phenotype, allele and haplotype frequencies among 51,857 blood donors in North India.

Authors:  Raj Makroo; Richa Gupta; Aakanksha Bhatia; Nakamatathil L Rosamma
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

4.  It is worthwhile filling in the remaining blank spots for blood group antigen frequencies.

Authors:  Christof Weinstock
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

Review 5.  The Rhesus Site.

Authors:  Franz F Wagner; Willy A Flegel
Journal:  Transfus Med Hemother       Date:  2014-09-15       Impact factor: 3.747

Review 6.  Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype.

Authors:  S Gerald Sandler; Leonard N Chen; Willy A Flegel
Journal:  Br J Haematol       Date:  2017-05-16       Impact factor: 6.998

7.  The DAU cluster: a comparative analysis of 18 RHD alleles, some forming partial D antigens.

Authors:  Kshitij Srivastava; Helene Polin; Sherry Lynne Sheldon; Franz Friedrich Wagner; Christoph Grabmer; Christian Gabriel; Gregory Andrew Denomme; Willy Albert Flegel
Journal:  Transfusion       Date:  2016-08-02       Impact factor: 3.157

8.  It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Authors:  S Gerald Sandler; Willy A Flegel; Connie M Westhoff; Gregory A Denomme; Meghan Delaney; Margaret A Keller; Susan T Johnson; Louis Katz; John T Queenan; Ralph R Vassallo; Clayton D Simon
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

9.  Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008.

Authors:  Tobias Jörg Legler; Sina Patricia Müller; Alexander Haverkamp; Simon Grill; Sinuhe Hahn
Journal:  Transfus Med Hemother       Date:  2009-05-14       Impact factor: 3.747

10.  RhCE protein variants in Southwestern Germany detected by serologic routine testing.

Authors:  Peter Bugert; Erwin A Scharberg; Christof Geisen; Inge von Zabern; Willy A Flegel
Journal:  Transfusion       Date:  2009-05-18       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.